Ionis Pharmaceuticals (IONS) PT Raised to $83 at Stifel

March 25, 2026 11:44 AM

Stifel analyst Paul Matteis raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $83.00 (from $77.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found